President Donald Trump gave a speech about pharmaceutical drug prices last month. During his presidential campaign and leading up to his inauguration, he accused pharmaceutical companies with “getting away with murder” for what they charge patients for prescriptions and promised to enact reforms to lower drug prices. After sixteen months in office, his speech last month consisted of few proposals as opposed to proposing meaningful legislation or guidelines that could have an immediate effect on prescription costs and actually led to pharmaceutical stocks rising.
Trump took aim at Pharmacy Benefit Managers (PBMs) who he referred to as “middlemen” who implement “gag rules” that forbid pharmacists from telling patients they are spending more than they need to on a prescription (you can read our blog on the laws proposed to combat PBM gag rules here). He also touched on other popular proposals such as removing barriers to generic medications